Direct intratumoral microdosing via the CIVO (R) platform reveals anti-tumor immune responses induced by the SUMO inhibitor TAK-981

CANCER RESEARCH(2019)

Cited 3|Views9
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined